IP Library › Granted Patent US 9,248,013
Granted Patent B2
US 9,248,013 · App. 13/740,069 · Granted Feb 2, 2016

3-Dimensional parylene scaffold cage

Inventors: Yu-Chong Tai (Pasadena, CA); Bo Lu (Pasadena, CA); Mark Humayun (Glendale, CA)
Assignees: California Institute of Technology; University of Southern California
A61F2/04A61L27/18A61L27/3804C12N5/0068A61L2430/16C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,248,013
App. No.
13/740,069
Granted
Feb 2, 2016
Kind
B2
Abstract

Thin parylene C membranes having smooth front sides and ultrathin regions (e.g., 0.01 μm to 5 μm thick) interspersed with thicker regions are disclosed. The back sides of the membranes can be rough compared with the smooth front sides. The membranes can be used in vitro to grow monolayers of cells in a laboratory or in vivo as surgically implantable growth layers, such as to replace the Bruch's membrane in the eye. The application further provides an implantable cage-like apparatus for culturing cells comprising the parylene membrane.

Claims (21)

1. A three-dimensional implantable apparatus for implanting cells comprising:

a top portion comprising a top face joined to each of four side faces, wherein said top portion is configured to allow microvilli or other cellular processes to connect to an anatomical structure external to said implantable apparatus;

a bottom portion comprising parylene having a first thickness and a second thickness; and

a gap between the top portion and the bottom portion, wherein the bottom portion is joined with each of the four side faces, the gap being suitable for growth of cells to be implanted,

wherein said cells are selected from the group consisting of cartilage cells, heart muscle cells, and retinal pigment epithelium (RPE) cells,

wherein the first thickness of the bottom portion is configured to allow proteins having a molecular weight of 70 kilodaltons or less to move through the bottom portion and to inhibit movement of proteins having a molecular weight greater and 100 kilodaltons through the bottom portion, and

wherein the second thickness of the bottom portion is greater than the first thickness of the bottom portion.

2. The three-dimensional implantable apparatus of claim 1 , wherein the parylene comprises parylene C.

3. The three-dimensional implantable apparatus of claim 2 , wherein the parylene C is between 0.1 μm to 10 μm thick.

4. The three-dimensional implantable apparatus of claim 2 , wherein the parylene C is between 0.15 μm to 0.8 μm thick.

5. The three-dimensional implantable apparatus of claim 1 , wherein the implantable apparatus consists entirely of a biocompatible material suitable for implantation in a human or animal body.

6. The three-dimensional implantable apparatus of claim 1 , wherein said bottom portion has permeability similar to a Bruch's membrane.

7. The three-dimensional implantable apparatus of claim 1 , wherein said bottom portion allows diffusion of cell nutrients and cell waste through the semi-permeable membrane to cells, facilitating cell growth as a monolayer on the membrane.

8. The three-dimensional implantable apparatus of claim 1 , wherein said top portion blocks cell migration.

9. A three-dimensional implantable apparatus for implanting cells, comprising:

a top portion comprising a top face joined to each of four side faces, wherein said top portion is configured to block cell migration but allow microvilli or other cellular processes to connect to an anatomical structure external to said implantable apparatus;

a bottom portion having a first thickness and a second thickness; and

a gap between the top portion and the bottom portion, wherein the bottom portion is joined with each of the four side faces, the gap being suitable for growth of cells to be implanted,

wherein said cells are selected from the group consisting of cartilage cells, heart muscle cells, and retinal pigment epithelium (RPE) cells,

wherein the first thickness of the bottom portion is configured to have a thickness between 0.01 μm and 5 μm, and

wherein the second thickness of the bottom portion is at least 2 times thicker than the first thickness of the bottom portion.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: HUMAYUN, MARK
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 032329/0033 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: TAI, YU-CHONG; LU, BO
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 032329/0072 →
Continuity (4)
Continuation In Part 13355426 · Jan 20, 2012
Provisional Application 61566965 · Dec 5, 2011
Provisional Application 61586276 · Jan 13, 2012
Related Publication 20130144399A1 · Jun 6, 2013